BRUKINSA patients can call the myBeiGene® patient support program to talk to a dedicated nurse: 1-833-BEIGENE (1-833-234-4363)
BRUKINSA works to help you take control of your
MZL is caused by rapid growth and spread of cancerous B cells.
The significance of blocking up to 100% of BTK on treatment responses has not been established.
In 2 clinical studies, 88 patients with MZL received BRUKINSA after at least 1 prior therapy. In both clinical studies:
responded to treatment,
known as the overall response rate
continued to respond
for a year or longer
BRUKINSA may cause serious side effects, including:
6% of patients discontinued treatment due to side effects in the trials.
These are not all the possible side effects of BRUKINSA.
Call your doctor for medical advice about side effects.
You may report side effects to the FDA at 1-800-FDA-1088.
|How long will I be on treatment with BRUKINSA?
You will take BRUKINSA for as long as your doctor thinks it is helping you, or for as long as side effects are manageable.
About 15 months was the median duration of treatment for patients in the clinical studies. The median marks the midpoint where half of the patients were still taking BRUKINSA, while half were no longer on treatment.
Remember, everyone responds differently to treatment, so the length of time that you take BRUKINSA could be shorter or longer.
Call 1-833-234-4363 to talk with an Oncology Nurse Advocate. Oncology Nurse Advocates are available 8 AM-8 PM ET Monday through Friday.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Taking BRUKINSA with certain other medications may affect how BRUKINSA works and can cause side effects.
These are not all the possible side effects of BRUKINSA. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
BRUKINSA is a prescription medicine used to treat adults with:
It is not known if BRUKINSA is safe and effective in children.